₹887.40
₹-9.25 (-1.03%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹14,289 Cr
P/E
40.66
ROE
5.62%
ROCE
6.41%
About Jubilant Pharmova Ltd
Jubilant Pharmova in radiopharma, allergy immunotherapy, contract development and manufacturing of sterile injectable, generics, contract research development and manufacturing and proprietary novel drugs businesses.
Founded
1978
CEO
Shyam S Bhartia
Employees
6,089
HQ
Noida, India
About Jubilant Pharmova Ltd
Jubilant Pharmova in radiopharma, allergy immunotherapy, contract development and manufacturing of sterile injectable, generics, contract research development and manufacturing and proprietary novel drugs businesses.
Founded:1978
CEO:Shyam S Bhartia
Employees:6,089
HQ:Noida, India
Finished Products
1Sales
₹1,902.80Cr2Service Income
₹272.00Cr3Sales of Services
₹88.80Cr4Other Operating Revenue
₹76.90CrRaw Materials
1Raw & Process Matrl. Consumed
₹706.30Cr2Others
₹282.50Cr3Other Purchases
₹14.80Cr4Purchases - Traded Goods
₹6.50CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹1,185
52W Low
₹786
Volume108.89K
Avg VolumeN/A
Beta0.69
Dividend Yield0.56%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
40.66x
Valuation
P/B Ratio
2.01x
Valuation
EPS
₹22.06
Valuation
Dividend Yield
0.56%
Valuation
ROE
5.62%
Profitability
ROCE
6.41%
Profitability
Revenue by Segment
Contribution & growth by business line
Radiopharma
+12.9%47.1%
₹3,388 Cr
Contract Development and Manufactur
+13.8%17.7%
₹1,271.7 Cr
Contract Research, Development and
+5.3%16.0%
₹1,151 Cr
Allergy Immunotherapy
+3.3%9.7%
₹701.3 Cr
Generics
-11.5%9.5%
₹685.3 Cr
Geographical Revenue Split
Domestic vs international exposure
Domestic
2.9%
International
97.1%
Americas and Europe91.1%
Rest of the world5.9%
Within India2.9%
Strategic Relations
Collaborations, joint ventures & subsidiaries
K
Kemira Coatings Ltd
United Kingdom
0.00% stakeN
Noble Chematur
Sweden
0.00% stakeT
Technimont
Italy
0.00% stakeH
Hydrogas
Denmark
0.00% stakeB
Biotim
Belgium
0.00% stakeT
Teutoburg
Germany
0.00% stakeC
Crown Decorative
United Kingdom
0.00% stakeForensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.51x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
7.3%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.